Analyzing the sizes and interactions of biomolecules using advanced ultracentrifugation techniques
Beckman Optima A/I Analytical Ultracentrifuge (AUC)
This study is using a special machine to look closely at the sizes and shapes of important molecules like proteins and DNA, helping scientists understand how they work and change in different situations, all while keeping the samples safe for more tests later.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Notre Dame NIH-funded |
| Lab location | 1 site (Notre Dame, United States) |
| Project ID | NIH-11102201 on NIH RePORTER |
What this research studies
This research focuses on using a state-of-the-art analytical ultracentrifuge to study the sizes, shapes, and interactions of biomolecules such as proteins and nucleic acids. By measuring how these molecules behave in a solution, researchers can gain insights into their biological functions and how they change under different conditions. The ultracentrifuge allows for precise measurements without damaging the samples, making it possible to conduct further analyses on the same material. This advanced technology aims to enhance the capabilities of scientists at the University of Notre Dame in their investigations of complex biological processes.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals under 18 years of age who are involved in studies related to biomolecular functions or treatments.
Not a fit: Patients who are over 18 years old or those not involved in biomolecular research may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to a better understanding of biomolecular interactions, which may improve the development of targeted therapies and diagnostics.
How similar studies have performed: Previous research utilizing analytical ultracentrifugation has shown success in characterizing biomolecular interactions, indicating that this approach is well-established and effective.
Where this research is happening
Notre Dame, United States
- University of Notre Dame — Notre Dame, United States (Active)
Researchers
- Principal investigator: Mobashery, Shahriar — University of Notre Dame
- Study coordinator: Mobashery, Shahriar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.